Status:

UNKNOWN

Metoclopramide, Azithromycin, or Nondrug Pretreatment for UGIB to Reduce Second Endoscopy

Lead Sponsor:

Waihong Chung

Conditions:

Gastro Intestinal Bleeding

Upper Gastrointestinal Bleeding

Eligibility:

All Genders

18+ years

Phase:

PHASE2

Brief Summary

Early endoscopy is an integral part of the management plan for patients presenting with clinical signs of severe or ongoing UGIB. An accurate endoscopic diagnosis and successful endoscopic hemostasis ...

Eligibility Criteria

Inclusion

  • 1\. Adult patients ≥ 18 years of age at the time of presentation;
  • 2\. Admitted to Rhode Island Hospital (RIH) emergency room or inpatient services;
  • 3\. Presented with hematemesis, coffee ground emesis, or melena;
  • 4\. Upper endoscopy is planned within 24 hours of presentation or onset of bleeding.

Exclusion

  • 1\. Known anaphylactic allergic reaction to erythromycin, azithromycin, and/or metoclopramide;
  • 2\. Concurrent use of certain medications associated with tardive dyskinesia (TD):
  • a. Fluphenazine,
  • b. Haloperidol,
  • c. Loxapine,
  • d. Paliperidone,
  • e. Perphenazine,
  • f. Pimozide,
  • g. Risperidone,
  • h. Thiothixene,
  • i. Trifluoperazine;
  • 3\. Concurrent use of certain medications associated with torsade de pointes:
  • a. Amiodarone,
  • b. Chlorpromazine,
  • c. Disopyramide,
  • d. Dofetilide,
  • e. Methadone,
  • f. Procainamide,
  • g. Quinidine,
  • h. Sotalol;
  • 4\. Known history of TD, ventricular arrhythmias , or long QT syndrome;
  • 5\. Already received erythromycin and/or azithromycin within the past 10 days, or metoclopramide within the past 4 days for other indications;
  • 6\. Recipient of hematopoietic stem cell transplant;
  • 7\. History of Neisseria gonorrhoeae infection;
  • 8\. Pregnancy;
  • 9\. Prior gastrectomy.

Key Trial Info

Start Date :

July 1 2020

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

July 1 2021

Estimated Enrollment :

435 Patients enrolled

Trial Details

Trial ID

NCT03840057

Start Date

July 1 2020

End Date

July 1 2021

Last Update

August 7 2020

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Rhode Island Hospital

Providence, Rhode Island, United States, 02906

Metoclopramide, Azithromycin, or Nondrug Pretreatment for UGIB to Reduce Second Endoscopy | DecenTrialz